In major reversal, Kennedy tells senators he won't take money from vaccine lawsuit
Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...
Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Kennedy to divest interest from HPV vaccine lawsuits
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?
We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...
Merck & Co. Inc. stock underperforms Monday when compared to competitors despite daily gains
Merck & Co. Inc. closed 27.25% short of its 52-week high of $134.63, which the company reached on June 25th.
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...
What to know about RFK Jr.'s financial ties with a personal industry law firm
Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.
RFK Jr pledges to divest from vaccine lawsuit after conflict of interest concerns
One of the concerns levied by Sen. Elizabeth Warren (D-MA) stemmed from Kennedy's financial ties to a lawsuit against Merck ...
Merck & Company Hold Rating: Promising Drug Developments Amid Uncertain Financial Outlook
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
Merck’s capvaxive receives positive EU CHMP opinion for pneumococcal vaccine
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
FiercePharma16h
Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Merck's SWOT analysis: pharma giant's stock faces China setback, PAH potential
Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial ...